Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory ...

The global therapeutic drug monitoring market would expand at a compound annual growth rate (CAGR) of 8.4% from USD 2.30 billion in 2024 to USD 3.44 billion by 2029. The main cause of this increase is ...

As you will see in the full video above, Brianne Gardner, senior wealth manager at Velocity Investments, Raymond James Canada ...

Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc. The growth of the Europe in vitro diagnostics (IVD) industry is heavily influenced by the ...

The global in vitro diagnostics (IVD) market has exhibited significant growth, with its valuation rising from $67,111 million in 2019 to an estimated $91,093 million by 2027. This ...

The market is segmented by device type, including drug delivery devices, in vitro diagnostics (IVD), urology and renal ... and elastomeric pumps, as well as specialty types, including insulin, patient ...

Equities research analysts at Leerink Partnrs lowered their Q1 2025 earnings estimates for shares of Thermo Fisher Scientific ...

Preeclampsia is a serious pregnancy complication characterized by high blood pressure and potential damage to vital organs such as the liver and kidneys. This condition affects approximately 2-8% of ...

Several of J&J’s key next-generation pipeline drugs are specialty drugs ... billion as of Dec. 11, 2024, Thermo Fisher Scientific TMO is the largest of the diagnostics and research companies ...

Specialty Diagnostics, and Laboratory Products and Services segments. The company was founded on October 11, 1960 and is headquartered in Waltham, MA. Read More on TMO: Thermo Fisher Scientific ...